"My conclusion is to do what you know best, learn a new technology from an expert, and consider participating in a clinical trial,” writes Gopal H. Badlani, MD.
Gopal H. Badlani, MD
"Patient perception is an important aspect of developing an effective treatment plan, and we should be able to arm patients with accurate data to help them make an informed decision," write Whitney Renee Smith, MD, and Gopal H. Badlani, MD.
In this interview, Sandip Vasavada, MD, discusses the rationale behind the recent amendment to the AUA/SUFU guideline for overactive bladder, the role of OAB drugs in the treatment of nocturia, and treatment of refractory OAB.
Earlier in 2019, the AUA and the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction published a joint guideline on the subject of incontinence after prostate treatment. In this interview, Jaspreet S. Sandhu, MD, a member of this guideline’s panel, explains the rationale behind the guideline and summarizes its key points.
"Fake news rules the world today. It certainly applies to the use of mesh in female pelvic health," writes Gopal H. Badlani, MD.
Although mesh has been banned for prolapse repair, midurethral slings remain a crucial treatment option for stress urinary incontinence.
In this interview, Richard Santucci, MD, discusses current trends in urologic trauma/reconstruction as well as the promise of penile transplantation.
The author’s career shortcomings are lessons in academic pursuit, leadership, and more.
In this interview, Margaret S. Pearle, MD, PhD, discusses the AUA’s guideline on medical management of stone disease and also touches on disposable ureteroscopes and percutaneous access.
J. Quentin Clemens, MD, explains how the annual AUA Census and the AUA Quality Registry (AQUA Registry) benefit practicing urologists.